Cornerstone Capital Management Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-25,400
| Closed | -$675K | – | 1355 |
|
2016
Q3 | $675K | Buy |
25,400
+5,200
| +26% | +$138K | 0.01% | 1021 |
|
2016
Q2 | $446K | Sell |
20,200
-62,651
| -76% | -$1.38M | ﹤0.01% | 1059 |
|
2016
Q1 | $2.43M | Buy |
82,851
+50,000
| +152% | +$1.47M | 0.02% | 674 |
|
2015
Q4 | $1.09M | Buy |
32,851
+17,551
| +115% | +$580K | 0.01% | 877 |
|
2015
Q3 | $553K | Sell |
15,300
-16,300
| -52% | -$589K | 0.01% | 985 |
|
2015
Q2 | $1.42M | Buy |
31,600
+27,900
| +754% | +$1.25M | 0.01% | 813 |
|
2015
Q1 | $113K | Buy |
+3,700
| New | +$113K | ﹤0.01% | 1255 |
|
2013
Q4 | – | Sell |
-5,200
| Closed | -$119K | – | 1271 |
|
2013
Q3 | $119K | Buy |
+5,200
| New | +$119K | ﹤0.01% | 1108 |
|